Maccura Biotechnology Co.Ltd (SHE:300463)
China · Delayed Price · Currency is CNY 9.45
+0.03 (0.32%)
Aug 11, 2026, 3:04 PM CST
SHE:300463 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 2,129 | 2,170 | 2,549 | 2,896 | 3,608 | 3,981 |
Revenue Growth | -9.19% | -14.84% | -11.98% | -19.75% | -9.35% | 7.47% |
Gross Profit Gross Profit Growth | 1,180 | 1,212 | 1,354 | 1,512 | 1,897 | 2,240 |
Operating Income Operating Income Growth | -62.75 | -12.71 | 262.16 | 331.6 | 815.54 | 1,240 |
Net Income Net Income Growth | -35.61 | -35.83 | 126.81 | 312.62 | 708.18 | 956.6 |
Earnings Per Share EPS Growth | -0.06 | -0.06 | 0.21 | 0.51 | 1.17 | 1.72 |
EPS Growth | - | - | -59.44% | -56.19% | -32.18% | 20.62% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Self Owned Products Self Owned Products Growth | 1,741 | 1,745 | 1,913 | 1,880 | 2,312 | 2,300 |
Agent Products Agent Products Growth | 375.65 | 406.04 | 612.02 | 981.45 | 1,256 | 1,635 |
Unallocated Other Business Unallocated Other Business Growth | 12.34 | 19.24 | 23.39 | 33.95 | 40.18 | 46.47 |
Total Total Growth | 2,129 | 2,170 | 2,549 | 2,896 | 3,608 | 3,981 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 814.29 | 717.36 | 731.52 | 1,147 | 1,251 | 637.16 |
Total Debt Total Debt Growth | 940.93 | 946.27 | 657.29 | 665.17 | 701.22 | 1,115 |
Net Cash (Debt) Net Cash Growth | -126.63 | -228.9 | 74.23 | 481.94 | 549.84 | -478.29 |
Net Cash Growth | - | - | -84.60% | -12.35% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.21 | -0.38 | 0.12 | 0.79 | 0.90 | -0.86 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 699.93 | 602.33 | 633.8 | 901.51 | 843.22 | 1,617 |
Capital Expenditures CapEx Growth | -624.91 | -749.07 | -963.02 | -877.9 | -987.74 | -601.78 |
Free Cash Flow Free Cash Flow Growth | 75.02 | -146.74 | -329.22 | 23.61 | -144.52 | 1,015 |
Free Cash Flow Growth | - | - | - | - | - | 71.23% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 55.43% | 55.86% | 53.13% | 52.20% | 52.57% | 56.28% |
Operating Margin | -2.95% | -0.59% | 10.29% | 11.45% | 22.60% | 31.16% |
Pretax Margin | -5.21% | -4.59% | 4.89% | 10.55% | 21.87% | 29.82% |
Profit Margin | -1.67% | -1.65% | 4.98% | 10.80% | 19.63% | 24.03% |
FCF Margin | 3.52% | -6.76% | -12.92% | 0.81% | -4.00% | 25.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.104 | - | 0.104 | 0.154 | 0.349 | 0.471 |
Dividend Per Share Growth | -32.48% | - | -32.48% | -55.89% | -25.86% | 9.30% |
Dividend Yield | 1.10% | - | 0.80% | 1.04% | 2.11% | 1.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 63.17 | 29.53 | 14.96 | 16.98 |
Forward PE | 59.06 | 24.87 | 16.54 | 17.39 | 12.45 | 14.61 |
P/FCF Ratio | 76.17 | - | - | 391.01 | - | 16.01 |
PS Ratio | 2.68 | 3.12 | 3.14 | 3.19 | 2.94 | 4.08 |